Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-06

FDA Approved: ETRAVIRINE — Supplemental Application (Patriot Pharmaceuticals)

View source ↗

Summary

The FDA approved a supplemental application for etravirine submitted by Patriot Pharmaceuticals. The action represents approval of a supplemental NDA related to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • etravirine (etravirine)

Snippet

SUPPL AP for ETRAVIRINE (ETRAVIRINE)